Norman David Eansor Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 months, 2 weeks ago
Norman David Eansor has an estimated net worth of at least $14.3 million*, as of Feb. 12, 2025. They own shares of TECH stock. They have sold 27,159 shares of TECH stock since 2021, for an estimated $13.7 million.
Norman David Eansor $TECH SEC Form 4 Insider Trading
Norman David Eansor has filed a total of 10 insider trades in $TECH since 2021. Their most recent trade was a sale of 200 shares, made on Nov 12, 2021. Their largest trade was a sale of 9,043 shares, made on Nov 12, 2021. We estimate that they now own shares of $TECH, worth an estimated $568,922.
Insider Trading at $TECH
There have been a total of 85 insider trades reported at $TECH since 2021, with 300 shares purchased and 293,000 shares sold. The most active insider traders in $TECH stock have been James Hippel, Charles R. Kummeth, and Norman David Eansor. The most recent trade was a sale of 17,040 shares reported by Roeland Nusse (None), made on Aug 25, 2025.
History of Insider Stock Trades by Norman David Eansor
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
MRKR
|
Purchase | 14,285 | Mar 16, 2021 | June 8, 2023, 9:35 p.m. |
TECH
|
Sale | 200 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
|
TECH
|
Sale | 300 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
|
TECH
|
Sale | 537 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
|
TECH
|
Sale | 400 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
|
TECH
|
Sale | 700 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
|
TECH
|
Sale | 9,043 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
|
TECH
|
Sale | 8,989 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
|
TECH
|
Sale | 2,535 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
|
TECH
|
Sale | 401 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
|
TECH
|
Sale | 4,054 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
$TECH Executives and Stock Owners with Insider Trades
-
James Hippel, Chief Financial Officer
-
Charles R. Kummeth, Chief Executive Officer
-
Norman David Eansor, President-Protein Sciences
-
Kim Kelderman, Pres. Diagnostics & Genom
-
Brenda S. Furlow, SVP - General Counsel
-
Brenda S. Furlow, SVP - GENERAL COUNSEL
-
Kim Kelderman, Chief Executive Officer
-
Charles R. Kummeth, CHIEF EXECUTIVE OFFICER
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.